Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
  • Alerts
  • Subscriptions

Evaluation of environmental tobacco smoke exposure of pediatric patients with chronic lung diseases

S Akyuzluer Gunes, G Ozcan, F Zirek, M N Tekin, F Bakar Ateş, N Cobanoglu
European Respiratory Journal 2022 60: 464; DOI: 10.1183/13993003.congress-2022.464
S Akyuzluer Gunes
1Ankara University School of Medicine, Department of Pediatrics, Ankara, Turkey, Ankara, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
G Ozcan
2Ankara University School of Medicine, Department of Pediatric Pulmonology, Ankara, Turkey, Ankara, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
F Zirek
2Ankara University School of Medicine, Department of Pediatric Pulmonology, Ankara, Turkey, Ankara, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M N Tekin
2Ankara University School of Medicine, Department of Pediatric Pulmonology, Ankara, Turkey, Ankara, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
F Bakar Ateş
3Ankara University Faculty of Pharmacy, Ankara, Turkey, Ankara, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
N Cobanoglu
2Ankara University School of Medicine, Department of Pediatric Pulmonology, Ankara, Turkey, Ankara, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

Introduction: Environmental tobacco smoke (ETS) can be harmful to children with chronic lung and respiratory diseases. Exposure to tobacco smoke exacerbates respiratory infections and primary diseases in these children. In our study, it was aimed to determine the tobacco use habits of the parents of the children in this patient group and to determine the ETS exposure of them.

Materials and Methods: Two hundred and fifty patients followed up with the diagnosis of chronic lung and/or respiratory tract diseases in the Department of Pediatric Pulmonary Diseases were included. Tobacco use habits of the parents were determined with a questionnaire. ETS exposure was determined by the measurement of plasma cotinine level and those with a level of 12 ng/ml and above were considered to be exposed to ETS.

Results: Although parents of 105 children (42%) reported there is no smoker among their household, the plasma cotinine levels of 72.4% of the patients were 12 ng/ml and above (figure-1). Cotinine values of children living in the same house with at least one smoker were significantly higher than the children living without a smoker. Cotinine levels of those who were exposed to tobacco smoke in the last seven days were significantly higher than those who were not. Cotinine levels were significantly higher in the group whose parents allow smoking in their cars and home compared to who do not allow (Figure-2).

Conclusions: Questionnaire results were not compatible with cotinine results. As there is no generally accepted plasma cotinine level for ETS exposure in children, further studies are necessary to determine a cutoff value specific to Turkish children.

  • Children
  • Chronic diseases
  • Smoking

Footnotes

Cite this article as Eur Respir J 2022; 60: Suppl. 66, 464.

This article was presented at the 2022 ERS International Congress, in session “-”.

This is an ERS International Congress abstract. No full-text version is available. Further material to accompany this abstract may be available at www.ers-education.org (ERS member access only).

  • Copyright ©the authors 2022
Previous
Back to top
Vol 60 Issue suppl 66 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Evaluation of environmental tobacco smoke exposure of pediatric patients with chronic lung diseases
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Evaluation of environmental tobacco smoke exposure of pediatric patients with chronic lung diseases
S Akyuzluer Gunes, G Ozcan, F Zirek, M N Tekin, F Bakar Ateş, N Cobanoglu
European Respiratory Journal Sep 2022, 60 (suppl 66) 464; DOI: 10.1183/13993003.congress-2022.464

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Evaluation of environmental tobacco smoke exposure of pediatric patients with chronic lung diseases
S Akyuzluer Gunes, G Ozcan, F Zirek, M N Tekin, F Bakar Ateş, N Cobanoglu
European Respiratory Journal Sep 2022, 60 (suppl 66) 464; DOI: 10.1183/13993003.congress-2022.464
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo

Jump To

  • Article
  • Info & Metrics
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Patient sentiments on tobacco industry ownership of respiratory therapies: A community survey
  • Sex-related differences and FEV1 decline among COPD patients: the French Palomb cohort
  • Establishment of an Alpha-1 research registry within the patient advocacy organization
Show more 06.03 - Tobacco, smoking control and health education

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society